Search research articles
Contact Us
Filters
Showing results (121-130 of 169) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
The Journal of Clinical Investigation
|
November 27, 2007
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice
Danielle C Shing, Maurizio Trubia, Francesco Marchesi, et al.
Chemmedchem
|
April 23, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oxime
Raffaella Amici, Chiara Bigogno, Roberto Boggio, et al.
Seminars in Oncology
|
March 26, 2023
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis
Laura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Journal of Medicinal Chemistry
|
May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models
Alessandra Fiore, Antonio Scarano, Giulia Antonini, et al.
Cell Death and Differentiation
|
November 30, 2021
Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer
Tania Velletri, Carlo Emanuele Villa, Domenica Cilli, et al.
Cancer Cell
|
April 30, 2019
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
Mohamed Elgendy, Marco Cirò, Amir Hosseini, et al.
Journal of Medicinal Chemistry
|
February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Greta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Developmental Cell
|
March 18, 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation
Gaetano Gargiulo, Samuel Levy, Gabriele Bucci, et al.
Chemmedchem
|
February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
Rossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 169) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
The Journal of Clinical Investigation
|
November 27, 2007
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice
Danielle C Shing, Maurizio Trubia, Francesco Marchesi, et al.
Chemmedchem
|
April 23, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oxime
Raffaella Amici, Chiara Bigogno, Roberto Boggio, et al.
Seminars in Oncology
|
March 26, 2023
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis
Laura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Journal of Medicinal Chemistry
|
May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models
Alessandra Fiore, Antonio Scarano, Giulia Antonini, et al.
Cell Death and Differentiation
|
November 30, 2021
Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer
Tania Velletri, Carlo Emanuele Villa, Domenica Cilli, et al.
Cancer Cell
|
April 30, 2019
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
Mohamed Elgendy, Marco Cirò, Amir Hosseini, et al.
Journal of Medicinal Chemistry
|
February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Greta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Developmental Cell
|
March 18, 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation
Gaetano Gargiulo, Samuel Levy, Gabriele Bucci, et al.
Chemmedchem
|
February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
Rossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
Page
of 17